ZBTB8OS-YARS Fusion FISH Probe
The ZBTB8OS-YARS Fusion FISH Probe is used to confirm a fusion of the ZBTB8OS and YARS genes. The fusion of the ZBTB8OS and YARS genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ZBTB8OS-YARS-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ZBTB8OS-YARS-20-AQAQ | 20 (40 μL) | 200 μL |
|
YARS Gene Summary
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Tyrosyl-tRNA synthetase belongs to the class I tRNA synthetase family. Cytokine activities have also been observed for the human tyrosyl-tRNA synthetase, after it is split into two parts, an N-terminal fragment that harbors the catalytic site and a C-terminal fragment found only in the mammalian enzyme. The N-terminal fragment is an interleukin-8-like cytokine, whereas the released C-terminal fragment is an EMAP II-like cytokine. [provided by RefSeq, Jul 2008]
Gene Name: Tyrosyl-tRNA Synthetase
Chromosome: CHR1: 33240839 -33283633
Locus: 1p35.1
ZBTB8OS Gene Summary
The Zinc Finger And BTB Domain Containing 8 Opposite Strand (ZBTB8OS) gene is located on chr1 :33087306-33116185 at 1p35.1.
Gene Name: Zinc Finger And BTB Domain Containing 8 Opposite Strand
Chromosome: CHR1: 33087306 -33116185
Locus: 1p35.1
Gene Diseases
The ZBTB8OS YARS Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|